The National Asthma Council Logo

 

 

Leading the attack against asthma

 Search website
Home About the NAC Strategy Managing Asthma Research Emergency
 
Inhaled Corticosteroids:

A Practical Perspective

 
Asthma Management Handbook Asthma Action Plans Spirometry Resources  Other Resources Information Papers Special Topics Professional Development  

Inhaled Corticosteroids:
A Practical Perspective
Home
Introduction
Efficacy of low-dose inhaled corticosteroids 
What has changed?
What is a minimum effective dose?
How is the minimum effective dose achieved?
A guide to dose adjustments in clinical practice
Prescribing in children
References
Acknowledgements
Copyright & Disclaimer
Content created Aug 2003
Page updated 31 Aug 2005

Get Adobe Reader

Get Adobe Flash Player
 

ForwardBackReferences
1. Suissa A, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001; 107: 937-44.[Back to document]
2. National Asthma Council. Asthma Management Handbook 2002. National Asthma Council, Melbourne, 2002.[Back to document]
3. Holt S, Suder A, Weatherall M, et al. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ 2001; 323: 1-8.[Back to document]
4. Powell H, Gibson PG. Inhaled corticosteroid doses in asthma: an evidence-based approach. Med J Aust 2003;178: 223-25.[Back to document]
5. Wong JY, Zacharin MR, Hocking N, et al. Growth and adrenal suppression in asthmatic children on moderate to high doses of fluticasone propionate. Paediatr Child Health 2002; 38: 59-62.[Back to document]
6. Macdessi JS, Randell TL, Donaghue KC, et al. Adrenal crisis in children treated with high-dose inhaled corticosteroids for asthma. Med J Aust 2003; 178: 214-16.[Back to document]
7. Wong CA, Walsh LJ Smith CJ, et al. Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 2000; 355: 1399-403.[Back to document]
8. Wilson JW, Robertson CF. Inhaled steroids - too much of a good thing? Med J Aust 2002; 177: 288-89.[Back to document]
9. Marks GB, Jalaludin, BB, Williamson M, et al. Use of "preventer" medications and written asthma management plans among adults with asthma in New South Wales. Med J Aust 2000; 173: 407-410.[Back to document]
10. National Asthma Campaign. Asthma Management Handbook 1998. National Asthma Campaign, Melbourne, 1998.[Back to document]
11. Lipworth B. Systemic adverse effects of inhaled corticosteroid therapy. A systematic review and meta-analysis. Arch Intern Med 1999; 159: 941-55. [Back to document]
12. Adverse Drug Reactions Advisory Committee. Fluticasone and adrenal crisis. Australian Adverse Drug Reactions Bulletin 2003; 22 (2): April. Available at: www.health.gov.au/tga/adr/aadrb/aadr0304.htm [Back to document]
13. Hawkins G, McMahon AD, Twaddle S, et al. Stepping down inhaled corticosteroids in asthma: randomised controlled trial. BMJ 2003; 326: 1115-20. [Back to document]
14. Scottish Intercollegiate Network, British Thoracic Society. British guidelines on the management of asthma: 2003. Thorax 2003; 58 (Suppl 1): 1-94. [Back to document]
15. Pierce R, Johns D. Spirometry: the measurement and interpretation of ventilatory function in clinical practice. National Asthma Campaign, Melbourne, 1995. Online format revised May 2002 available at: www.nationalasthma.org.au/publications/spiro/index.htm [Back to document]
16. O'Byrne P, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med. 2001; 164 (8 Pt 1):1392-97. [Back to document]
17. Reddel HK, Jenkins CR, Marks GB et al. Optimal asthma control, starting with high doses of inhaled budesonide. Eur Respir J 2000; 16: 226-35. [Back to document]
18. National Institutes of Health, National Heart, Lung and Blood Institute. Global Initiative for Asthma. Global strategy for asthma management and prevention. Available at: http://www.ginasthma.com
19. Pauwels RA, Lofdahl C-G, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1405-411. [Back to document]
20. Greening AP, Ind PW, Northfield M, et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 219-24. [Back to document]
21. Woolcock AJ, Lundback B, Ringdal N, et al. Comparison of addition of salmeterol to inhaled steroids with doubling the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153: 1481-488. [Back to document]
22. van Asperen PP, Mellis C, Sly PD, for the Thoracic Society of Australia and New Zealand. The role of corticosteroids in the management of childhood asthma. Med J Aust 2002; 176: 169-74. [Back to document]
23. Pedersen S, Hansen OR. Budesonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol 1995; 95: 29-33. [Back to document]